Skip to main content
Signal8

Silva Francisco

SEC insider (Form 3/4/5 filer). CIK 0001527241. VP of Research and Development at BioRestorative Therapies, Inc. (BRTX). 2 reported Form 4/5 transactions since Sep 2024; latest on Oct 6, 2025. Located in MELVILLE, NY.

Companies Silva Francisco has filed insider reports for

  • BioRestorative Therapies, Inc. (BRTX): Director, Officer, VP of Research and Development
Silva Francisco profile photo

Silva Francisco

CIK: 0001527241

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BioRestorative Therapies, Inc. logo
BRTX

BioRestorative Therapies, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • BioRestorative Therapies, Inc. logo
    BRTX

    BioRestorative Therapies, Inc.

    Oct 6, 2025
    Award
    Direct
    11.7K shares at avg. $1.60$19K
  • BioRestorative Therapies, Inc. logo
    BRTX

    BioRestorative Therapies, Inc.

    Feb 14, 2025
    Award

    Stock Option

    Direct
    769K shares-

1-2 of 2